logo
Japan Seasonings, Dressings and Sauces Market Assessment and Forecasts Report 2024-2025 & 2029 Featuring Ajinomoto, Kewpie, Kikkoman, House Foods, Kagome, Nestle, Unilever, Kraft Heinz

Japan Seasonings, Dressings and Sauces Market Assessment and Forecasts Report 2024-2025 & 2029 Featuring Ajinomoto, Kewpie, Kikkoman, House Foods, Kagome, Nestle, Unilever, Kraft Heinz

Yahoo19-05-2025
The Japanese seasonings, dressings, and sauces sector will grow from JPY2,651.6 billion in 2024 to JPY2,926.3 billion in 2029, with a 2% CAGR. Tomato pastes and purées lead growth, while Ajinomoto, Kewpie, and Kikkoman dominate. Modern retail remains the top distribution channel.
Dublin, May 19, 2025 (GLOBE NEWSWIRE) -- The "Japan Seasonings, Dressings and Sauces - Market Assessment and Forecasts to 2029" has been added to ResearchAndMarkets.com's offering.
The Japanese seasonings, dressings, and sauces market is on a progressive growth trajectory, with expectations to surge from JPY2,651.6 billion ($17.5 billion) in 2024 to JPY2,926.3 billion ($20.6 billion) by 2029, reflecting a compound annual growth rate (CAGR) of 2%.
In volume terms, the sector is predicted to rise from 2.6 billion kg in 2024 to 2.7 billion kg by 2029, growing at a CAGR of 0.9%. Within this vibrant market landscape, condiment sauces reign supreme, dominating both value and volume categories. Notably, the tomato pastes and purees segment is poised to demonstrate the swiftest growth in both value and volume from 2024 to 2029.
In examining distribution channels, modern retail emerged as the predominant platform in 2024. Pioneering companies like Ajinomoto Group, Kewpie Corporation, and Kikkoman Corporation are fundamental in propelling market dynamics.
Scope
In 2024, per capita consumption of seasonings, dressings, and sauces in Japan surpassed both regional and global figures.
Japan's per capita intake of condiment sauces eclipsed other categories within the sector in 2024.
Modern retail channels held the largest distribution share within the Japanese market.
Ajinomoto Group captured an 11.2% value share in 2024, while Kewpie Corporation and Kikkoman Corporation secured 8.4% and 6.6% shares, respectively.
Reasons to Buy
Recognize high-potential categories to identify lucrative market opportunities based on comprehensive value and volume analysis.
Existing and prospective players can scrutinize key distribution channels to spot trends and capitalize on emerging opportunities.
Gain insights into the competitive landscape via detailed company share analyses to devise effective market positioning strategies.
Our analysts have highlighted upcoming market changes, providing a nuanced understanding of opportunities ripe for revenue expansion over the next five years.
The report also delivers analyses on key macro-economic indicators, such as real GDP, nominal GDP, consumer price index, household consumption expenditures, demographic statistics, and labor market trends.
Key Topics Covered:
Report Scope
Executive Summary
Market Environment
Sector Deep Dive
Japan Seasonings, Dressings and Sauces Sector Snapshot
Category Deep Dive
Per Capita Consumption Analysis by Category
Market Size Analysis by Category
Distribution Analysis
Competitive Environment
Health & Wellness Analysis
Packaging Analysis
City Deep Dive
Consumer Graphics
Demographic Analysis
Macroeconomic Analysis
Methodology
Definitions
Appendix
A selection of companies mentioned in this report includes, but is not limited to:
Ajinomoto Group
Kewpie Corporation
Kikkoman Corporation
House Foods Group Inc.
Kagome Co. Ltd
Nestle
Unilever
The Kraft Heinz Company
For more information about this report visit https://www.researchandmarkets.com/r/4cm90n
About ResearchAndMarkets.comResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

US tariffs on Chinese graphite spark opportunity for India's Epsilon
US tariffs on Chinese graphite spark opportunity for India's Epsilon

Yahoo

time23 minutes ago

  • Yahoo

US tariffs on Chinese graphite spark opportunity for India's Epsilon

(Fixes typo in paragraph 6 in word "Carolina." No other changes to text.) By Aditi Shah NEW DELHI (Reuters) -India's Epsilon Advanced Materials is moving swiftly to close deals to supply critical components to Japanese and South Korean battery makers in the U.S., a top executive said, after Washington imposed anti-dumping duties on Chinese imports. The U.S. in July imposed a punitive 93.5% tariff on import of graphite anode materials from China, creating an opportunity for India's Epsilon to break Beijing's monopoly on supplies of the key battery component. Indeed, U.S.-based battery makers are eager to secure alternative suppliers as the higher levies disrupt supply chains and stoke uncertainty, including over future price rises. Vikram Handa, managing director of Epsilon, which makes graphite anode materials for EV batteries, expressed confidence over some new supply deals. "Last month, they were saying let's wait and see how things go. Now we think in the next 60 to 80 days, we will close our contracts," said Handa. Epsilon, which announced plans for a $650 million factory in North Carolina in October 2023, has been working on getting permits and environmental clearances, while waiting for firm orders before putting a shovel in the ground. "The numbers now start making sense for customers to buy from the U.S.," said Handa, adding that the plant, which will have capacity of 30,000 tonnes of anode materials, is expected to be up and running by mid-2027. An EV battery is made up of four components - anode, cathode, electrolyser and separator. The anode contributes to fast-charging and vehicle range. The U.S. needs 500,000 tonnes of anode materials a year for its EV and energy storage battery needs, which were met largely by China, which refines over 90% of the world's graphite into the material used in almost all EV battery anodes. Mumbai-based Epsilon also has plans to invest over $1.1 billion in a 100,000-tonne anode materials facility in India's Karnataka state, but has yet to see serious interest in India. Handa said low Chinese prices were a draw for Indian companies, but he was trying to persuade them to buy at least 20% from Epsilon, so that "if China closes the tap," they had an alternative supplier. "If it is zero (demand for Epsilon's anodes) right now, how will I put up a plant?" he asked. "I hope this rare earth story doesn't play out the same way for battery materials," given Indian companies dependence on them, he said. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Japan sees record 3.43 million July foreign visitors
Japan sees record 3.43 million July foreign visitors

UPI

time3 hours ago

  • UPI

Japan sees record 3.43 million July foreign visitors

Japan' s tourism recorded 3.43 million visitors in July, up by 4.4 percent, a record high for the month, the Japan National Tourism Organization said Wednesday. File Photo by Keizo Mori/UPI | License Photo Aug. 20 (UPI) -- Japan recorded 3.43 million foreign visitors in July a record high for the month, the Japan National Tourism Organization said Wednesday. The total was 4% higher than the previous July's record of 3.29 million set last year, with younger travelers on school trips driving the increase. China had the largest number of visitors to Japan at 974,500, up 25.5%, South Korea at 678,600, down 10.4%, Taiwan at 604, 200 up 5.7% and the United States up 10.3% with 277,100 visitors. Taiwanese visitors rose to an all-time high due to new flight routes and increased flights to Japan. Travels from Hong Kong and South Korea showed a decrease because of a social media rumor that Japan would suffer from a devastating natural disaster in July. The Japanese organization said it will closely analyze market trends to pursue the promotion of strategic inbound tourism. The government aims to boost travel spending per person to $1,355 and raise the average overnight stay in regional areas to two nights, in its three year fiscal 2025 plan.

ClearStrand-ASD, First-of-Its-Kind Autism Screening Tool, Now Available in Japan
ClearStrand-ASD, First-of-Its-Kind Autism Screening Tool, Now Available in Japan

Business Wire

time4 hours ago

  • Business Wire

ClearStrand-ASD, First-of-Its-Kind Autism Screening Tool, Now Available in Japan

NORTH BRUNSWICK, N.J.--(BUSINESS WIRE)-- LinusBio, a leader in precision exposome medicine, announced today that ClearStrand-ASD™, its biochemical autism screening test, is now available to patients and providers in Japan for research use through its partnership with YAC Bio. This milestone marks LinusBio's first international expansion and represents a significant step in the company's mission to enable earlier identification of autism spectrum disorder (ASD) globally. Today marks a transformational moment in our mission to make early autism screening accessible worldwide. Share ClearStrand-ASD requires only a strand of hair to detect molecular signatures associated with autism spectrum disorder. This innovative, non-invasive approach provides healthcare providers with an objective screening method that can help identify ASD risk as early as one month of age, allowing families to pursue intervention during the most crucial period of early development. "Today marks a transformational moment in our mission to make early autism screening accessible worldwide," said Dr. Manish Arora, Founder and CEO of LinusBio. "Japan represents our first step beyond U.S. borders, and we chose this market because of its sophisticated healthcare infrastructure and commitment to pediatric developmental care. Japanese families dealing with autism concerns will now have access to the same cutting-edge screening technology that has already helped multiple American families get answers earlier than ever before." The Japanese launch builds on ClearStrand-ASD's successful rollout across the United States, where it is now available in 49 states. YAC Bio will partner with hospital systems in Japan to facilitate the implementation of this first-of-its-kind biomarker test for autism. LinusBio's expansion into Japan is facilitated through its existing partnership with YAC Bio (part of Y.A.C. Holdings), the Japanese multinational that invested over 1 billion yen in the company. Beyond providing market access, Y.A.C. Holdings contributes manufacturing expertise and automation capabilities that support LinusBio's scaling efforts globally. "By combining the world's only hair-cutting robotics technology with the innovative hair exposome analysis developed by LinusBio in the United States, we have contributed to the development of the world's first biomarker screening test for autism spectrum disorder. Following its launch in the U.S., we are now offering this test in Japan through our group company, YAC Bio," said Takefumi Momose, President and CEO, Y.A.C. Holdings Co., Ltd. "We sincerely hope that this test will support individuals, families, and communities in Japan who are concerned about autism." The Japan availability of ClearStrand-ASD represents the first phase of LinusBio's international expansion strategy, with the company evaluating additional markets where ClearStrand-ASD could address unmet needs in early autism detection. About ClearStrand-ASD ClearStrand-ASD is a biochemical test intended to help health care providers rule out autism spectrum disorder (ASD) in children 1 to 48 months. The test analyzes a strand of hair to map the dynamic patterns of an individual's unique biological responses at a molecular level to environmental exposures over time and uses an algorithm to assess the likelihood of autism. It is not a genetic test and must be ordered by a licensed health care provider (Rx only). ClearStrand-ASD is performed at LinusBio's CLIA-certified laboratory (CLIA #31d2307499). For more information visit: About LinusBio LinusBio (Linus Biotechnology Inc.) is a patient-centric, breakthrough science precision exposome medicine company headquartered in New Jersey. The Company's program pipeline comprises precision exposome medicine biomarkers and target discovery across disease domains for which historically no molecular endpoints have been available in medical practice or for clinical trials, including CNS (autism spectrum disorder, amyotrophic lateral sclerosis), gastroenterology (inflammatory bowel disease), renal disease and oncology. LinusBio is actively exploring additional international partnerships to expand global access to its innovative diagnostic solutions. For more information, visit About Y.A.C. Holdings Y.A.C. Holdings is a Japan-based company specializing in developing, designing, and manufacturing mechatronics-related products. The company collaborates with LinusBio on hardware innovations to scale testing capacity, driving breakthroughs in robotics and laboratory automation.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store